225 related articles for article (PubMed ID: 32285434)
1. Cervical dystonia - improving the effectiveness of botulinum toxin therapy.
Tyślerowicz M; Kiedrzyńska W; Adamkiewicz B; Jost WH; Sławek J
Neurol Neurochir Pol; 2020; 54(3):232-242. PubMed ID: 32285434
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin in cervical dystonia revisited - recent advances and unanswered questions.
Sławek J; Jost WH
Neurol Neurochir Pol; 2021; 55(2):125-132. PubMed ID: 33822352
[TBL] [Abstract][Full Text] [Related]
3. Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.
Camargo CH; Cattai L; Teive HA
Toxins (Basel); 2015 Jun; 7(6):2321-35. PubMed ID: 26110508
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
5. [Cervical dystonia treatment with botulin toxin].
Tomczykiewicz K
Pol Merkur Lekarski; 2016 Aug; 41(242):107-10. PubMed ID: 27591450
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin treatment of axial and cervical dystonia.
Benecke R; Dressler D
Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
[TBL] [Abstract][Full Text] [Related]
7. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
Marion MH; Humberstone M; Grunewald R; Wimalaratna S
Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
[TBL] [Abstract][Full Text] [Related]
8. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review.
Erro R; Picillo M; Pellecchia MT; Barone P
Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368692
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin therapy for cervical dystonia.
Jankovic J
Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for cervical dystonia: addressing treatment failure and improving outcomes.
Pena AB
Neurol Neurochir Pol; 2020; 54(3):218-219. PubMed ID: 32602934
[TBL] [Abstract][Full Text] [Related]
11. Tremor in Idiopathic Cervical Dystonia - Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap Classification.
Pandey S; Kreisler A; Drużdż A; Biering-Sørensen B; Sławek J; Tatu L; Jost WH
Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():13. PubMed ID: 32775027
[TBL] [Abstract][Full Text] [Related]
12. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.
van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591
[TBL] [Abstract][Full Text] [Related]
13. Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review.
Nijmeijer SW; Koelman JH; Kamphuis DJ; Tijssen MA
Parkinsonism Relat Disord; 2012 Jul; 18(6):731-6. PubMed ID: 22575237
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt DP; Noble S
Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of cervical dystonia patients classified by the COL-CAP concept and treated with ultrasound-guided botulinum neurotoxin.
Szabó M; DO Kiem D; Gárdián G; Szpisjak L; Salamon A; Klivényi P; Zádori D
Ideggyogy Sz; 2023 Jan; 76(1-2):37-45. PubMed ID: 36892297
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
17. Determinants of disability in cervical dystonia.
van den Dool J; Tijssen MA; Koelman JH; Engelbert RH; Visser B
Parkinsonism Relat Disord; 2016 Nov; 32():48-53. PubMed ID: 27553512
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin therapy for cervical dystonia.
Walker FO
Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):749-66, vi. PubMed ID: 14580035
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
